INSM Insmed Incorporated - Common Stock
$128.81
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$90–$213
31% of range
分析师评级
BUY
30 analysts
目标价
$200
+55% upside
P/E (TTM)
-20.3
ROE
-128.4%
净利润率
-210.5%
INSM 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$128.81
市值
$27.89B
P/E (TTM)
-20.3
每股收益 (TTM)
$-6.42
营收 (TTM)
$606M
股息收益率
—
ROE
-128.4%
负债/权益
0.7
52周区间
$90 – $213
INSM 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$606M
2016-12-31
→
2025-12-31
EPS
$-6.42
2019-12-31
→
2025-12-31
自由现金流
$-968M
2016-12-31
→
2025-12-31
利润率
-210.5%
2019-12-31
→
2019-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
INSM
同行中位数
P/E (TTM)
-20.3
17.7
P/S (TTM) (市销率 (TTM))
46.0
6.8
P/B (市净率)
37.7
6.4
EV / EBITDA (企业价值 / EBITDA)
-21.7
—
Price / FCF (股价/自由现金流)
-28.8
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
INSM
同行中位数
Operating Margin (营业利润率)
-205.6%
—
Net Profit Margin (净利润率)
-210.5%
20.3%
ROA
-59.5%
11.4%
ROE
-128.4%
16.8%
ROIC
-97.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
INSM
同行中位数
Debt / Equity (负债/股东权益比率)
0.7
—
Current Ratio (流动比率)
3.8
3.4
Quick Ratio (速动比率)
3.4
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
INSM
同行中位数
Revenue YoY (营收同比增长)
66.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
35.2%
—
Revenue CAGR 5Y (营收5年复合年增长率)
29.8%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
INSM
同行中位数
INSM 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
30 位分析师
- 强烈买入 9 30.0%
- 买入 20 66.7%
- 持有 1 3.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
22 位分析师 · 2026-08-18
中位数
$197.50
← 低于所有目标
$128.81
最低
$169.00
最高
$243.00
中位数目标
$197.50
+53.3%
平均目标
$200.05
+55.3%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.02%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.06 | $-0.80 | 0.74% |
| 2026年3月31日 | $-0.76 | $-0.98 | 0.22% |
| 2025年12月31日 | $-1.54 | $-1.32 | -0.22% |
| 2025年9月30日 | $-1.75 | $-1.37 | -0.38% |
| 2025年6月30日 | $-1.70 | $-1.32 | -0.38% |
| 2025年3月31日 | $-1.42 | $-1.36 | -0.06% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| RVMD | — | — | — | — | — | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | · | |
| Cost of Revenue | $123M | $86M | $66M | $55M | $44M | $40M | $24M | $2M | $0 | $0 | · | · | |
| Gross Profit | · | · | · | · | · | · | $112M | $7M | $0 | · | · | · | |
| R&D Expense | $771M | $598M | $571M | $398M | $273M | $181M | $132M | $145M | $110M | $123M | $74M | $56M | |
| SG&A Expense | $701M | $461M | $345M | $266M | $234M | $204M | $211M | $168M | $79M | $51M | $43M | $31M | |
| Operating Expenses | $1.85B | $1.24B | $1.01B | $703M | $564M | $430M | $372M | $317M | $189M | $173M | $117M | $87M | |
| Operating Income | $-1.25B | $-878M | $-710M | $-457M | $-375M | $-265M | $-235M | $-307M | $-189M | $-173M | $-117M | $-87M | |
| Interest Expense | $84M | $85M | $82M | $26M | $40M | $30M | $28M | $25M | $6M | $3M | $3M | $2M | |
| Other Non-op | $-2M | $29.0K | $2M | $-6M | $-3M | $405.0K | $-531.0K | $602.0K | $300.0K | $119.0K | $-33.0K | $141.0K | |
| Pretax Income | $-1.27B | $-910M | $-747M | $-480M | $-436M | $-293M | $-254M | $-324M | $-193M | $-176M | $-120M | $-90M | |
| Income Tax | $5M | $4M | $3M | $1M | $-2M | $1M | $777.0K | $201.0K | $-272.0K | $98.0K | $-2M | $-10M | |
| Net Income | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| EPS (Basic) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| Shares (Basic) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| Shares (Diluted) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| EBITDA | $-1.25B | $-878M | $-704M | $-452M | $-366M | $-256M | $-230M | $-304M | $-186M | $-171M | $-116M | · |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $555M | $482M | $1.07B | $717M | $533M | $487M | $495M | $381M | $163M | $283M | $159M | |
| Short-term Investments | $920M | $879M | $298M | $74M | $0 | · | · | · | · | · | · | · | |
| Receivables | $141M | $52M | $41M | $30M | $24M | $17M | $19M | $6M | $0 | · | · | · | |
| Inventory | $132M | $99M | $83M | $70M | $67M | $50M | $28M | $7M | $0 | · | · | · | |
| Prepaid Expense | $91M | $37M | $24M | $25M | $29M | $24M | $20M | $11M | $8M | $6M | $5M | $5M | |
| Current Assets | $1.79B | $1.62B | $929M | $1.27B | $837M | $623M | $555M | $519M | $389M | $168M | $288M | $165M | |
| PP&E (Net) | $103M | $80M | $65M | $56M | $53M | $54M | $60M | $23M | $12M | $10M | $8M | $8M | |
| PP&E (Gross) | $164M | $130M | $110M | $96M | $90M | $82M | $79M | $37M | $23M | $18M | $13M | $11M | |
| Accum. Depreciation | $61M | $50M | $45M | $39M | $37M | $28M | $19M | $14M | $11M | $8M | $5M | $3M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $0 | · | · | · | · | · | · | |
| Intangibles | $98M | $59M | $64M | $69M | $74M | $49M | $54M | $59M | $58M | · | · | · | |
| Total Assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Accounts Payable | $80M | $73M | $65M | $50M | $36M | $43M | $13M | $18M | $15M | $10M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | $61M | $38M | $40M | $38M | $17M | $17M | $11M | $10M | |
| Current Liabilities | $469M | $298M | $226M | $190M | $135M | $119M | $85M | $80M | $45M | $28M | $22M | $20M | |
| Capital Leases | $12M | $9M | $11M | $15M | $21M | $21M | $29M | · | · | · | · | · | |
| Other Non-current Liabilities | $6M | $499.0K | $3M | $9M | $20M | $9M | $11M | $0 | $765.0K | $693.0K | $572.0K | $23.0K | |
| Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833M | $520M | $481M | $396M | $101M | $83M | $45M | $45M | |
| Long-term Debt | $547M | $1.12B | $1.18B | $1.15B | $800M | $450M | $450M | $450M | $55M | $55M | $25M | $25M | |
| Total Debt | $541M | $1.10B | $1.16B | $1.13B | $567M | $356M | $336M | $317M | $56M | $55M | $25M | · | |
| Common Stock | $2M | $2M | $1M | $1M | $1M | $1M | $897.0K | $773.0K | $766.0K | $620.0K | $618.0K | $498.0K | |
| Paid-in Capital | $6.37B | $4.65B | $3.11B | $2.78B | $2.67B | $2.11B | $1.80B | $1.49B | $1.32B | $919M | $900M | $657M | |
| Retained Earnings | $-5.64B | $-4.36B | $-3.45B | $-2.70B | $-2.27B | $-1.83B | $-1.54B | $-1.28B | $-958M | $-765M | $-589M | $-471M | |
| AOCI | $1M | $-2M | $-745.0K | $756.0K | $968.0K | $193.0K | $-10.0K | $-9.0K | $-3.0K | $-65.0K | · | · | |
| Stockholders' Equity | $739M | $285M | $-332M | $88M | $410M | $276M | $262M | $208M | $361M | $154M | $312M | $186M | |
| Liabilities + Equity | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Shares Outstanding | 214,255,853 | 179,383,000 | 147,978,000 | 135,654,000 | 118,738,000 | 102,763,060 | 89,682,387 | 77,307,521 | 76,610,508 | 62,019,889 | 61,813,995 | 49,806,131 |
现金流 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $6M | $5M | $9M | $9M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Stock-based Comp | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | |
| Deferred Tax | $-27.0K | $-29.0K | $-54.0K | $-231.0K | $-3M | $0 | $0 | $0 | $-417.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $0 | $0 | · | · | |
| Other Non-cash | · | · | $133M | $18M | $20M | $29M | $-28M | $36M | $12M | $9M | $-89.0K | · | |
| Operating Cash Flow | $-935M | $-684M | $-536M | $-400M | $-363M | $-219M | $-251M | $-258M | $-160M | $-147M | $-101M | $-64M | |
| CapEx | $33M | $22M | $13M | $10M | $7M | $6M | $42M | $13M | $3M | $4M | $3M | $5M | |
| Investing Cash Flow | $-65M | $-583M | $-224M | $-35M | $-64M | $-7M | $-42M | $-15M | $-3M | $-4M | $-3M | · | |
| Stock Issued | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | $0 | $223M | $109M | |
| Net Stock Activity | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | · | $223M | · | |
| Financing Cash Flow | $954M | $1.34B | $168M | $793M | $613M | $271M | $285M | $387M | $381M | $31M | $228M | · | |
| Net Change in Cash | $-45M | $73M | $-592M | $357M | $184M | $45M | $-8M | $114M | $219M | $-120M | $124M | $45M | |
| Taxes Paid | $4M | $2M | $2M | $2M | $2M | $814.0K | $339.0K | $154.0K | $166.0K | $85.0K | $-3M | $9M | |
| Free Cash Flow | $-968M | $-706M | $-550M | $-410M | $-371M | $-226M | $-293M | $-271M | $-163M | $-151M | $-104M | · | |
| Levered FCF | $-1.05B | $-791M | $-632M | $-437M | $-411M | $-255M | $-321M | $-297M | $-169M | $-154M | $-107M | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 82.3% | · | · | · | · | · | |
| Operating Margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | · | · | · | · | |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | · | · | · | · | |
| Pretax Margin | -209.7% | -250.2% | -244.8% | -195.7% | -231.6% | -178.0% | -185.8% | -3295.1% | · | · | · | · | |
| EBITDA Margin | -205.6% | -241.5% | -230.7% | -184.2% | -194.2% | -155.8% | -168.6% | -3088.3% | · | · | · | · | |
| ROA | -59.5% | -54.5% | -50.2% | -33.2% | -42.6% | -38.2% | -37.8% | -60.8% | -55.0% | -59.3% | -40.2% | · | |
| ROE | -128.4% | -237.7% | 241.3% | -1660.7% | -95.0% | -92.9% | -89.9% | -129.8% | -74.7% | -75.6% | -47.5% | · | |
| ROIC | -97.8% | -63.5% | -86.5% | -37.8% | -38.2% | -42.1% | -39.5% | -58.6% | -45.3% | -82.9% | -34.3% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 | 5.2 | 6.5 | 6.5 | 8.7 | 6.0 | 12.9 | · | |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 | 4.6 | 5.9 | 6.3 | 8.5 | 5.8 | 12.7 | · | |
| Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| LT Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| Interest Coverage | -14.9 | -10.3 | -8.7 | -17.3 | -9.3 | -9.0 | -8.5 | -12.1 | -31.9 | -49.6 | -40.7 | · |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.8 | 0.8 | 1.0 | 1.4 | 0.7 | · | · | · | · | |
| Receivables Turnover | 6.3 | 7.8 | 8.6 | 9.1 | 9.2 | 9.2 | 11.0 | 3.6 | · | · | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 66.7% | 19.2% | 24.4% | 30.2% | 14.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.2% | 24.5% | 22.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.8% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | $12M | |
| Net Income TTM | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| Market Cap | $37.29B | $12.38B | $4.59B | $2.71B | $3.23B | $3.42B | $2.14B | $1.01B | $2.39B | $821M | $1.12B | · | |
| Enterprise Value | $36.40B | $12.05B | $4.96B | $2.69B | $3.08B | $3.24B | $1.99B | $836M | $2.06B | $713M | $864M | · | |
| P/E | -27.1 | -12.4 | -5.8 | -5.1 | -7.0 | -11.1 | -7.9 | · | · | · | · | · | |
| P/S | 61.5 | 34.1 | 15.0 | 11.0 | 17.2 | 20.8 | 15.7 | 103.1 | · | · | · | · | |
| P/B | 50.5 | 43.4 | -13.8 | 30.8 | 7.9 | 12.4 | 8.2 | 4.9 | 6.6 | 5.3 | 3.6 | · | |
| P / Tangible Book | 73.8 | 136.7 | · | · | 16.1 | 15.1 | · | · | · | · | · | · | |
| P / Cash Flow | -39.9 | -18.1 | -8.6 | -6.8 | -8.9 | -15.6 | -8.5 | -3.9 | -15.0 | -5.6 | -11.1 | · | |
| P / FCF | -38.5 | -17.5 | -8.3 | -6.6 | -8.7 | -15.2 | -7.3 | -3.7 | -14.7 | -5.4 | -10.8 | · | |
| EV / EBITDA | -29.2 | -13.7 | -7.0 | -5.9 | -8.4 | -12.7 | -8.7 | -2.8 | -11.1 | -4.2 | -7.5 | · | |
| EV / FCF | -37.6 | -17.1 | -9.0 | -6.5 | -8.3 | -14.4 | -6.8 | -3.1 | -12.7 | -4.7 | -8.3 | · | |
| EV / Revenue | 60.0 | 33.1 | 16.3 | 11.0 | 16.4 | 19.7 | 14.6 | 85.0 | · | · | · | · | |
| Earnings Yield | -3.7% | -8.1% | -17.2% | -19.6% | -14.2% | -9.0% | -12.6% | · | · | · | · | · |
损益表 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $425M | $306M | $264M | $142M | $107M | $93M | $104M | $93M | $90M | $76M | $84M | $79M | $77M | $65M | $59M | $68M | |
| Cost of Revenue | $67M | $47M | $44M | $29M | $28M | $21M | $26M | $21M | $21M | $17M | $18M | $17M | $17M | $14M | $13M | $13M | |
| R&D Expense | $210M | $209M | $255M | $186M | $177M | $153M | $180M | $151M | $147M | $121M | $137M | $109M | $197M | $128M | $125M | $100M | |
| SG&A Expense | $247M | $247M | $212M | $186M | $155M | $148M | $143M | $119M | $107M | $93M | $90M | $91M | $84M | $80M | $73M | $76M | |
| Operating Expenses | $427M | $459M | $584M | $508M | $420M | $341M | $335M | $307M | $379M | $221M | $262M | $227M | $313M | $213M | $211M | $195M | |
| Operating Income | $-2M | $-153M | $-320M | $-366M | $-313M | $-248M | $-230M | $-213M | $-289M | $-146M | $-178M | $-148M | $-236M | $-148M | $-151M | $-128M | |
| Interest Expense | · | · | · | · | $21M | $22M | $22M | $21M | $21M | $21M | $21M | $20M | $21M | $20M | $16M | $3M | |
| Other Non-op | $-531.0K | $-736.0K | $-2M | $-603.0K | $453.0K | $132.0K | $-445.0K | $2M | $-269.0K | $-1M | $2M | $285.0K | $-488.0K | $-111.0K | $1M | $-2M | |
| Pretax Income | $-11M | $-162M | $-327M | $-369M | $-320M | $-256M | $-234M | $-220M | $-300M | $-157M | $-185M | $-158M | $-244M | $-159M | $-160M | $-131M | |
| Income Tax | $2M | $1M | $2M | $1M | $1M | $912.0K | $1M | $1M | $838.0K | $589.0K | $998.0K | $544.0K | $530.0K | $483.0K | $125.0K | $372.0K | |
| Net Income | $-13M | $-164M | $-328M | $-370M | $-322M | $-257M | $-236M | $-221M | $-301M | $-157M | $-186M | $-159M | $-245M | $-160M | $-160M | $-131M | |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| Shares (Basic) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| Shares (Diluted) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| EBITDA | $-2M | $-153M | · | $-366M | $-313M | $-248M | · | $-213M | $-289M | $-146M | · | $-148M | $-236M | $-148M | · | $-128M |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $582M | $510M | $335M | $1.28B | $403M | $555M | $461M | $1.25B | $596M | · | $487M | $613M | $969M | · | $415M | |
| Short-term Investments | $616M | $641M | $920M | $1.35B | $572M | $796M | $879M | $1.01B | $0 | $0 | · | $299M | $305M | $30M | · | $99M | |
| Receivables | $215M | $179M | $141M | $65M | $55M | $48M | $52M | $42M | $40M | $37M | · | $36M | $31M | $31M | · | $27M | |
| Inventory | $142M | $133M | $132M | $121M | $108M | $101M | $99M | $98M | $90M | $83M | · | $78M | $77M | $71M | · | $66M | |
| Prepaid Expense | $116M | $78M | $91M | $66M | $62M | $55M | $37M | $41M | $41M | $43M | · | $27M | $26M | $29M | · | $25M | |
| Current Assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | $1.40B | $1.62B | $1.65B | $1.42B | $759M | · | $927M | $1.05B | $1.13B | · | $632M | |
| PP&E (Net) | $107M | $103M | $103M | $90M | $90M | $88M | $80M | $75M | $73M | $69M | · | $65M | $62M | $60M | · | $54M | |
| PP&E (Gross) | $174M | $166M | $164M | $147M | $145M | $141M | $130M | $124M | $120M | $115M | · | $108M | $104M | $100M | · | $92M | |
| Accum. Depreciation | $67M | $64M | $61M | $57M | $55M | $52M | $50M | $49M | $47M | $46M | · | $43M | $42M | $41M | · | $38M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | · | $136M | $136M | $136M | · | $136M | |
| Intangibles | $93M | $96M | $98M | $85M | $56M | $57M | $59M | $60M | $61M | $62M | $64M | $65M | $66M | $67M | · | $70M | |
| Total Assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Accounts Payable | $75M | $73M | $80M | $80M | $74M | $58M | $73M | $65M | $51M | $44M | · | $65M | $56M | $57M | · | $12M | |
| Current Liabilities | $439M | $361M | $469M | $417M | $312M | $239M | $298M | $259M | $524M | $421M | · | $197M | $204M | $188M | · | $138M | |
| Capital Leases | $8M | $10M | $12M | $8M | $8M | $8M | $9M | $10M | $12M | $14M | · | $13M | $13M | $15M | · | $17M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $6M | $5M | $499.0K | $3M | $3M | $3M | · | $6M | $11M | $10M | · | $11M | |
| Total Liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | $1.70B | $1.74B | $1.57B | $1.77B | $1.62B | · | $1.61B | $1.59B | $1.56B | · | $1.02B | |
| Long-term Debt | $547M | $547M | $547M | $547M | $547M | $1.12B | · | $972M | $1.19B | $1.18B | · | $1.17B | $1.17B | $1.16B | · | $800M | |
| Total Debt | $544M | $542M | · | $540M | $539M | $1.11B | · | $955M | $1.17B | $1.16B | · | $1.15B | $1.14B | $1.13B | · | $785M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $6.57B | $6.50B | $6.37B | $6.25B | $6.18B | $4.71B | $4.65B | $4.61B | $3.94B | $3.14B | · | $2.97B | $2.95B | $2.81B | · | $2.51B | |
| Retained Earnings | $-5.81B | $-5.80B | $-5.64B | $-5.31B | $-4.94B | $-4.62B | $-4.36B | $-4.12B | $-3.90B | $-3.60B | · | $-3.26B | $-3.10B | $-2.86B | · | $-2.54B | |
| AOCI | $-3M | $4.0K | $1M | $2M | $2M | $-902.0K | $-2M | $547.0K | $-3M | $-2M | · | $-2M | $-1M | $1M | · | $-1M | |
| Stockholders' Equity | $757M | $705M | $739M | $946M | $1.25B | $99M | $285M | $483M | $39M | $-465M | $-332M | $-289M | $-156M | $-45M | $88M | $-30M | |
| Liabilities + Equity | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Shares Outstanding | 218,281,059 | 216,521,841 | 214,255,853 | 212,583,015 | 211,110,658 | 181,900,074 | 179,382,635 | 178,846,991 | 166,666,599 | 148,560,882 | 147,978,000 | 143,049,197 | 142,750,463 | 136,429,216 | 135,654,000 | 121,726,199 |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $46M | $39M | $31M | $43M | $39M | $27M | $26M | $23M | $21M | $20M | $20M | $18M | $16M | $15M | $16M | |
| Deferred Tax | $0 | $0 | $-27.0K | $0 | $0 | $0 | $-29.0K | $0 | $0 | $0 | $-54.0K | $0 | $0 | $0 | $-231.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-89M | $-223M | $-248M | $-220M | $-206M | $-262M | $-196M | $-181M | $-123M | $-184M | $-131M | $-136M | $-123M | $-146M | $-103M | $-90M | |
| CapEx | $6M | $3M | $17M | $2M | $3M | $10M | $7M | $4M | $7M | $5M | $2M | $3M | $5M | $3M | $5M | $582.0K | |
| Investing Cash Flow | $25M | $266M | $389M | $-762M | $228M | $80M | $132M | $-1.00B | $-7M | $295M | $2M | $7M | $-274M | $42M | $20M | $49M | |
| Stock Issued | · | · | $0 | $-256.0K | · | · | $-12.0K | $371M | · | · | $114M | $0 | · | · | $259M | $33M | |
| Financing Cash Flow | $27M | $30M | $34M | $33M | $858M | $29M | $159M | $397M | $781M | $3M | $123M | $1M | $44M | $-399.0K | $743M | $37M | |
| Net Change in Cash | $-37M | $72M | $176M | $-950M | $881M | $-152M | $94M | $-785M | $651M | $113M | $-5M | $-126M | $-356M | $-105M | $659M | $-1M | |
| Taxes Paid | $696.0K | $3M | $111.0K | $1M | $677.0K | $2M | $248.0K | $689.0K | $354.0K | $1M | $75.0K | $518.0K | $358.0K | $1M | $91.0K | $432.0K | |
| Free Cash Flow | · | $-226M | · | · | · | $-272M | · | · | · | $-189M | · | · | · | $-150M | · | · | |
| Levered FCF | · | · | · | · | · | $-294M | · | · | · | $-210M | · | · | · | $-170M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| Net Margin | -3.1% | -53.5% | · | -259.9% | -299.5% | -276.4% | · | -236.0% | -332.8% | -208.1% | · | -201.0% | -317.0% | -245.0% | · | -193.6% | |
| Pretax Margin | -2.7% | -53.0% | · | -259.0% | -298.3% | -275.4% | · | -235.0% | -331.8% | -207.3% | · | -200.3% | -316.3% | -244.2% | · | -193.1% | |
| EBITDA Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| ROA | -0.58% | -8.4% | · | -16.8% | -15.0% | -17.3% | · | -13.1% | -18.5% | -11.7% | · | -13.7% | -19.6% | -12.0% | · | -11.4% | |
| ROE | -1.3% | -40.7% | · | -51.8% | -49.9% | 140.3% | · | -227.3% | 514.2% | 61.7% | · | 99.6% | 439.1% | -424.7% | · | -55.2% | |
| ROIC | -0.14% | -12.4% | · | -24.7% | -17.6% | -20.7% | · | -14.9% | -23.9% | -20.9% | · | -17.3% | -24.0% | -13.7% | · | -17.0% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.5 | · | 4.6 | 6.7 | 5.9 | · | 6.4 | 2.7 | 1.8 | · | 4.7 | 5.2 | 6.0 | · | 4.6 | |
| Quick Ratio | 3.1 | 3.9 | · | 4.2 | 6.1 | 5.2 | · | 5.8 | 2.5 | 1.5 | · | 4.2 | 4.6 | 5.5 | · | 3.9 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 30.2 | -2.5 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 24.4 | -2.0 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| Interest Coverage | · | · | · | · | -14.7 | -11.5 | · | -10.1 | -13.6 | -6.9 | · | -7.3 | -11.4 | -7.4 | · | -38.1 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 3.1 | 2.7 | · | 2.6 | 2.3 | 2.2 | · | 2.4 | 2.5 | 2.2 | · | 2.5 | 2.6 | 2.3 | · | 2.9 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $981M | $649M | · | $436M | $384M | $352M | · | $338M | $322M | $297M | · | $289M | $275M | $251M | · | $233M | |
| Net Income TTM | $-869M | $-1.11B | · | $-1.17B | $-1.10B | $-935M | · | $-837M | $-861M | $-721M | · | $-695M | $-631M | $-481M | · | $-434M | |
| Market Cap | $23.27B | $35.41B | · | $30.61B | $21.25B | $13.88B | · | $13.06B | $11.17B | $4.03B | · | $3.61B | $3.01B | $2.33B | · | $2.62B | |
| Enterprise Value | $22.66B | $34.72B | · | $29.47B | $19.93B | $13.78B | · | $12.54B | $11.09B | $4.60B | · | $3.97B | $3.23B | $2.46B | · | $2.89B | |
| P/E | -25.0 | -29.0 | · | -23.5 | -15.9 | -13.4 | · | -13.6 | -11.4 | -5.3 | · | -4.9 | -4.4 | -4.4 | · | -5.9 | |
| P/S | 23.7 | 54.6 | · | 70.2 | 55.3 | 39.4 | · | 38.6 | 34.7 | 13.6 | · | 12.5 | 10.9 | 9.3 | · | 11.3 | |
| P/B | 30.7 | 50.2 | · | 32.4 | 17.0 | 139.9 | · | 27.0 | 287.7 | -8.7 | · | -12.5 | -19.3 | -52.1 | · | -87.5 | |
| P / Tangible Book | 44.1 | 74.8 | · | 42.2 | 20.1 | · | · | 45.4 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -159.0 | · | · | · | -52.9 | · | · | · | -21.9 | · | · | · | -15.9 | · | · | |
| P / FCF | · | -156.5 | · | · | · | -51.0 | · | · | · | -21.4 | · | · | · | -15.5 | · | · | |
| EV / EBITDA | -14635.9 | -226.5 | · | -80.5 | -63.7 | -55.5 | · | -58.8 | -38.4 | -31.6 | · | -26.9 | -13.7 | -16.6 | · | -22.7 | |
| EV / FCF | · | -153.5 | · | · | · | -50.6 | · | · | · | -24.4 | · | · | · | -16.4 | · | · | |
| EV / Revenue | 23.1 | 53.5 | · | 67.6 | 51.9 | 39.1 | · | 37.1 | 34.4 | 15.5 | · | 13.7 | 11.7 | 9.8 | · | 12.4 | |
| Earnings Yield | -4.0% | -3.4% | · | -4.3% | -6.3% | -7.5% | · | -7.4% | -8.8% | -18.9% | · | -20.4% | -22.9% | -22.6% | · | -17.0% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $606M | $364M | $305M | $245M | $188M |
| 营业利润率 % | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% |
| 净收入 | $-1.28B | $-914M | $-750M | $-482M | $-435M |
| 稀释后每股收益 (EPS) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 |
| 流动比率 | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 |
| 速动比率 | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-968M | $-706M | $-550M | $-410M | $-371M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 751 家申报者 · $16.3B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 137 (+28 与上一季度对比) | 113 (+21 与上一季度对比) | 248 (-30 与上一季度对比) | 231 (+3 与上一季度对比) | +38.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $1246915143 | 11694946 | 7.63% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1109696908 | 10407962 | 6.79% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $1043902026 | 9790865 | 6.39% | 股份 |
| BAKER BROS. ADVISORS LP | $937841355 | 8796111 | 5.74% | 股份 |
| Capital International Investors | $878338960 | 8238124 | 5.37% | 股份 |
| Darwin Global Management, Ltd. | $673600013 | 6431163 | 4.12% | 股份 |
| STATE STREET CORP | $645282792 | 6052174 | 3.95% | 股份 |
| Artisan Partners Limited Partnership | $580195955 | 5441718 | 3.55% | 股份 |
| RTW INVESTMENTS, LP | $516347866 | 4842880 | 3.16% | 股份 |
| AMERIPRISE FINANCIAL INC | $483856150 | 4538102 | 2.96% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $389229811 | 3661786 | 2.38% | 股份 |
| NORGES BANK | $360124083 | 3377641 | 2.20% | 股份 |
| MAVERICK CAPITAL LTD | $229314244 | 2150762 | 1.40% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $218358293 | 2048005 | 1.34% | 股份 |
| Qube Research & Technologies Ltd | $179370451 | 1682334 | 1.10% | 股份 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $173743795 | 1629561 | 1.06% | 股份 |
| Integral Health Asset Management, LLC | $170592000 | 1600000 | 1.04% | 股份 |
| CITADEL ADVISORS LLC | $160586566 | 1506158 | 0.98% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $149433474 | 1401552 | 0.91% | 股份 |
| Balyasny Asset Management L.P. | $141423967 | 1326430 | 0.87% | 股份 |
| Paradigm Biocapital Advisors LP | $141375668 | 1325977 | 0.86% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $132445710 | 1242222 | 0.81% | 股份 |
| Pictet Asset Management Holding SA | $129804038 | 1220353 | 0.79% | 股份 |
| D. E. Shaw & Co., Inc. | $120259044 | 1127922 | 0.74% | 股份 |
| Hood River Capital Management LLC | $112683586 | 1056871 | 0.69% | 股份 |
| Castle Hook Partners LP | $105906712 | 993310 | 0.65% | 股份 |
| JENNISON ASSOCIATES LLC | $96501143 | 905094 | 0.59% | 股份 |
| TimesSquare Capital Management, LLC | $95626169 | 584798 | 0.58% | 股份 |
| Polar Capital Holdings Plc | $94984773 | 890872 | 0.58% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $92119680 | 864000 | 0.56% | 买入期权 |
| FIL Ltd | $91289537 | 856214 | 0.56% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $91280154 | 856126 | 0.56% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $90627000 | 850000 | 0.55% | 股份 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84788663 | 795242 | 0.52% | 股份 |
| GOLDMAN SACHS GROUP INC | $81873498 | 767900 | 0.50% | 卖出期权 |
| AMERICAN CENTURY COMPANIES INC | $81002980 | 759735 | 0.50% | 股份 |
| Caption Management, LLC | $78973434 | 740700 | 0.48% | 卖出期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $77763723 | 729354 | 0.48% | 股份 |
| GOLDMAN SACHS GROUP INC | $77305085 | 725052 | 0.47% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76670442 | 719100 | 0.47% | 卖出期权 |
| Clearbridge Investments, LLC | $76331581 | 715922 | 0.47% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76297272 | 715600 | 0.47% | 买入期权 |
| ALLIANCEBERNSTEIN L.P. | $75676402 | 462796 | 0.46% | 股份 |
| Ensign Peak Advisors, Inc | $74948636 | 702951 | 0.46% | 股份 |
| Affinity Asset Advisors, LLC | $69303000 | 650000 | 0.42% | 股份 |
| TWO SIGMA ADVISERS, LP | $68745800 | 395000 | 0.42% | 股份 |
| Caption Management, LLC | $67170600 | 630000 | 0.41% | 买入期权 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $67152581 | 629831 | 0.41% | 股份 |
| Squarepoint Ops LLC | $65727392 | 616464 | 0.40% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $65302719 | 612596 | 0.40% | 股份 |
| Railway Pension Investments Ltd | $64473114 | 604700 | 0.39% | 股份 |
| Swiss National Bank | $63280249 | 593512 | 0.39% | 股份 |
| Artia Global Partners LP | $62804724 | 589052 | 0.38% | 股份 |
| EVENTIDE ASSET MANAGEMENT, LLC | $62220874 | 583665 | 0.38% | 股份 |
| Davern Capital Partners, LP | $59688435 | 559824 | 0.37% | 股份 |
| Candriam S.C.A. | $59131121 | 555131 | 0.36% | 股份 |
| Point72 Asset Management, L.P. | $57254620 | 536997 | 0.35% | 股份 |
| Long Focus Capital Management, LLC | $56295360 | 528000 | 0.34% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49576321 | 303182 | 0.30% | 股份 |
| BlackRock, Inc. | $49204384 | 461493 | 0.30% | 股份 |
| Bridgewater Associates, LP | $48553895 | 455392 | 0.30% | 股份 |
| JANE STREET GROUP, LLC | $48160254 | 451700 | 0.29% | 买入期权 |
| WELLINGTON MANAGEMENT GROUP LLP | $47494625 | 445457 | 0.29% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $46668960 | 437713 | 0.29% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $44365435 | 416108 | 0.27% | 股份 |
| Palo Alto Investors LP | $44138548 | 413980 | 0.27% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $42729564 | 400765 | 0.26% | 股份 |
| Eagle Health Investments LP | $40955941 | 384130 | 0.25% | 股份 |
| Prosight Management, LP | $40047432 | 375609 | 0.24% | 股份 |
| GATEWAY INVESTMENT ADVISERS LLC | $38916300 | 365000 | 0.24% | 股份 |
| Rock Springs Capital Management LP | $38612433 | 362150 | 0.24% | 股份 |
| CITADEL ADVISORS LLC | $38084664 | 357200 | 0.23% | 买入期权 |
| NEUBERGER BERMAN GROUP LLC | $37086246 | 347836 | 0.23% | 股份 |
| JANE STREET GROUP, LLC | $36975816 | 346800 | 0.23% | 卖出期权 |
| ENVESTNET ASSET MANAGEMENT INC | $35930149 | 336997 | 0.22% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $34817934 | 326561 | 0.21% | 股份 |
| BANK OF AMERICA CORP /DE/ | $33116173 | 310600 | 0.20% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $33084186 | 310300 | 0.20% | 买入期权 |
| VICTORY CAPITAL MANAGEMENT INC | $32695129 | 306651 | 0.20% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $32437642 | 304236 | 0.20% | 股份 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $31622852 | 296594 | 0.19% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30876512 | 289594 | 0.19% | 股份 |
| Defilade Capital Management, L.P. | $30049568 | 281838 | 0.18% | 股份 |
| SAMLYN CAPITAL, LLC | $29812765 | 279617 | 0.18% | 股份 |
| CITADEL ADVISORS LLC | $29181894 | 273700 | 0.18% | 卖出期权 |
| RHUMBLINE ADVISERS | $29076813 | 272715 | 0.18% | 股份 |
| First Turn Management, LLC | $28131794 | 263851 | 0.17% | 股份 |
| Bank of New York Mellon Corp | $27412962 | 257109 | 0.17% | 股份 |
| California Public Employees Retirement System | $26692317 | 250350 | 0.16% | 股份 |
| Vestal Point Capital, LP | $26655000 | 250000 | 0.16% | 股份 |
| Fiera Capital Corp | $26535159 | 248876 | 0.16% | 股份 |
| TD Asset Management Inc | $25608205 | 240182 | 0.16% | 股份 |
| Caption Management, LLC | $25162320 | 236000 | 0.15% | 股份 |
| Trails Edge Capital Partners, LP | $24557891 | 230331 | 0.15% | 股份 |
| ADAR1 Capital Management, LLC | $24364802 | 228520 | 0.15% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23363000 | 219123 | 0.14% | 股份 |
| Assenagon Asset Management S.A. | $23271947 | 218270 | 0.14% | 股份 |
| DNB Asset Management AS | $22737675 | 213259 | 0.14% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $22675515 | 212676 | 0.14% | 股份 |
| Longaeva Partners L.P. | $21454716 | 201226 | 0.13% | 股份 |
公司内部人士 48 位内幕人士 · 29 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 2026年7月23日 M | 259058 | 0 | 67 | $-31886073 |
| Timothy Whitten | President & CEO | 2012年6月1日 P | 10000 | 0 | 0 | $0 |
| Geoffrey Allan | President, CEO and Chairman | 2009年3月31日 M | 1715557 | 0 | 0 | $0 |
| Sara Bonstein | Chief Financial Officer | 2026年6月3日 S | 69082 | 0 | 1 | $-245857 |
| Paolo Tombesi | Chief Financial Officer | 2019年1月3日 A | 10669 | 0 | 0 | $0 |
| Andrew T Drechsler | Chief Financial Officer | 2017年3月1日 M | 15000 | 0 | 0 | $0 |
| Kevin P Tully | Executive VP & CFO | 2011年12月21日 A | 377344 | 0 | 0 | $0 |
| Steve C Glover | President Follow-on Biologics | 2009年3月31日 M | 372113 | 0 | 0 | $0 |
| Ronald D Gunn | Executive Vice President & COO | 2005年12月8日 A | 40074 | 0 | 0 | $0 |
| Samuele Butera | SVP, GM, Global Respiratory | 2026年6月23日 A | 7342 | 0 | 0 | $0 |
| Michael Alexander Smith | Chief Legal Officer | 2026年6月22日 S | 37648 | 0 | 2 | $-393852 |
| Orlov S Nicole Schaeffer | Chief People Strategy Officer | 2026年1月2日 M | 41754 | 0 | 9 | $-26423350 |
| John Drayton Wise | Chief Commercial Officer | 2022年5月23日 A | 78137 | 0 | 0 | $0 |
| John Soriano | Chief Compliance Officer | 2021年9月7日 M | 35204 | 0 | 0 | $0 |
| Christine A Pellizzari | Chief Legal Officer | 2021年5月15日 F | 149985 | 0 | 0 | $0 |
| John Goll | Chief Accounting Officer | 2020年1月3日 A | 14166 | 0 | 0 | $0 |
| Paul Streck | Chief Medical Officer | 2018年8月8日 A | 15996 | 0 | 0 | $0 |
| Eugene Jeffrey Sullivan | Chief Med. & Scientific Ofc. | 2017年5月17日 A | — | 0 | 0 | $0 |
| Mark Quigley | Vice President, Quality | 2015年5月12日 M | 0 | 0 | 0 | $0 |
| Peggy Berry | Vice President, Regulatory | 2015年2月26日 A | — | 0 | 0 | $0 |
| Matthew Pauls | Chief Commercial Officer | 2014年6月2日 A | — | 0 | 0 | $0 |
| Andrea Holtzman Drucker | SVP, Gen. Counsel & Corp Sec. | 2013年6月3日 M | 45000 | 0 | 0 | $0 |
| Renu Gupta | EVP & Chief Medical Officer | 2013年5月23日 A | 19507 | 0 | 0 | $0 |
| Nicholas A. Labella Jr. | Chief Scientific Officer | 2011年12月21日 A | — | 0 | 0 | $0 |
| Nicholas Lee Gurreri | Senior VP, Commercial Ops | 2011年1月31日 A | — | 0 | 0 | $0 |
| Doug Farrar | Vice President, ITP | 2009年3月31日 M | 292055 | 0 | 0 | $0 |
| Michael Duncan | Principal Financial Officer | 2005年12月8日 A | — | 0 | 0 | $0 |
| Philip J Young | Chief Business Officer and EVP | 2005年12月8日 A | — | 0 | 0 | $0 |
| Thomas A Keuer | Sr VP, ITP (Subsidiary) | 2005年12月8日 A | — | 0 | 0 | $0 |
| Melvin Sharoky MD | 董事 | 2026年5月13日 A | 246081 | 0 | 3 | $-6849100 |
| David W J Mcgirr | 董事 | 2026年2月9日 G | 53400 | 0 | 0 | $0 |
| Clarissa Desjardins | 董事 | 2022年5月11日 A | 35595 | 0 | 0 | $0 |
| Elizabeth M Anderson | 董事 | 2022年5月11日 A | 42317 | 0 | 0 | $0 |
| Leo Lee | 董事 | 2022年5月11日 A | 53265 | 0 | 0 | $0 |
| David R Brennan | 董事 | 2022年5月11日 A | 95521 | 0 | 0 | $0 |
| Alfred Altomari | 董事 | 2022年5月11日 A | 43141 | 0 | 0 | $0 |
| Steinar J Engelsen | 董事 | 2021年11月1日 P | 320802 | 0 | 0 | $0 |
| Donald J Hayden JR | 董事 | 2019年4月9日 M | 62197 | 0 | 0 | $0 |
| Myrtle S Potter | 董事 | 2018年5月15日 A | 25510 | 0 | 0 | $0 |
| Randall W Whitcomb | 董事 | 2015年3月10日 M | 69188 | 0 | 0 | $0 |
| Richard S Kollender | 董事 | 2013年10月31日 M | 24598 | 0 | 0 | $0 |
| Dennis M Lanfear | 董事 | 2010年6月9日 A | 168404 | 0 | 0 | $0 |
| Graham K Crooke | 董事 | 2010年6月9日 A | 228404 | 0 | 0 | $0 |
| Kenneth G Condon | 董事 | 2010年6月9日 A | 168504 | 0 | 0 | $0 |
| FMR LLC | 10% 所有者 | 2013年7月22日 S | 2221 | 0 | 0 | $0 |
| Roger Adsett | — | 2026年8月10日 M | 98744 | 0 | 2 | $-32207190 |
| Martina Flammer M.D. | — | 2026年8月6日 M | 60486 | 0 | 5 | $-5110195 |
| Carol Schafer | — | 2026年5月13日 A | 66622 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 121 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 3.71% | 7509 NS | 2026年4月30日 | N-PORT |
| IBB · iShares Trust | 2.19% | 1576476 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 1.94% | 11797 SH | 2026年8月8日 | 每日 |
| FMED · Fidelity Covington Trust | 1.79% | 6875 NS | 2026年5月31日 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1.70% | 15835 NS | 2026年5月31日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 1.44% | 92576 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 1.16% | 7968 NS | 2026年5月31日 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1.11% | 2081 NS | 2026年5月31日 | N-PORT |
| BBP · ETFis Series Trust I | 1.10% | 4801 NS | 2026年4月30日 | N-PORT |
| SPIT · RBB Fund, Inc. | 1.06% | 2228 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.92% | 34830 NS | 2026年4月30日 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0.90% | 80500 NS | 2026年4月30日 | N-PORT |
| IWP · iShares Trust | 0.81% | 1239854 SH | 2026年8月8日 | 每日 |
| HRTS · Tema ETF Trust | 0.71% | 3449 NS | 2026年5月31日 | N-PORT |
| LFSC · RBB Fund, Inc. | 0.62% | 6050 NS | 2026年5月31日 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0.58% | 35661 NS | 2026年4月30日 | N-PORT |
| WINN · Harbor ETF Trust | 0.50% | 40138 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.47% | 98313 NS | 2026年4月30日 | N-PORT |
| IYH · iShares Trust | 0.46% | 128330 SH | 2026年8月8日 | 每日 |
| FFSM · FIDELITY COVINGTON TRUST | 0.40% | 37505 NS | 2026年4月30日 | N-PORT |
| FTC · First Trust Exchange-Traded Alpha... | 0.39% | 36063 NS | 2026年4月30日 | N-PORT |
| SMLF · iShares Trust | 0.39% | 123385 SH | 2026年8月8日 | 每日 |
| IMCG · iShares Trust | 0.38% | 116453 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.33% | 632581 SH | 2026年8月8日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.32% | 1435651 SH | 2026年8月8日 | 每日 |
| HEQQ · J.P. Morgan Exchange-Traded Fund ... | 0.30% | 695 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.26% | 2487127 SH | 2026年8月8日 | 每日 |
| VOT · VANGUARD INDEX FUNDS | 0.25% | 830249 SH | 2026年8月8日 | 每日 |
| FDG · AMERICAN CENTURY ETF TRUST | 0.24% | 9338 NS | 2026年5月31日 | N-PORT |
| SIZE · iShares Trust | 0.23% | 7501 SH | 2026年8月8日 | 每日 |
| FFLG · FIDELITY COVINGTON TRUST | 0.22% | 9640 NS | 2026年4月30日 | N-PORT |
| EUSA · iShares, Inc. | 0.22% | 31591 SH | 2026年8月8日 | 每日 |
| FEX · First Trust Exchange-Traded Alpha... | 0.21% | 22539 NS | 2026年4月30日 | N-PORT |
| ESLV · Strategy Shares | 0.20% | 176 NS | 2026年4月30日 | N-PORT |
| IWR · iShares Trust | 0.20% | 873374 SH | 2026年8月8日 | 每日 |
| JMOM · J.P. Morgan Exchange-Traded Fund ... | 0.20% | 32329 NS | 2026年4月30日 | N-PORT |
| ESLG · Strategy Shares | 0.20% | 279 NS | 2026年4月30日 | N-PORT |
| FAD · First Trust Exchange-Traded Alpha... | 0.19% | 6824 NS | 2026年4月30日 | N-PORT |
| IMCB · iShares Trust | 0.19% | 24582 SH | 2026年8月8日 | 每日 |
| ESUM · Strategy Shares | 0.19% | 2146 NS | 2026年4月30日 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0.17% | 3643 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.16% | 155 NS | 2026年5月31日 | N-PORT |
| QYLD · Global X Funds | 0.16% | 98226 NS | 2026年4月30日 | N-PORT |
| QCLR · Global X Funds | 0.15% | 45 NS | 2026年4月30日 | N-PORT |
| QYLG · Global X Funds | 0.15% | 1572 NS | 2026年4月30日 | N-PORT |
| QTR · Global X Funds | 0.15% | 32 NS | 2026年4月30日 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.15% | 24910 NS | 2026年5月31日 | N-PORT |
| QRMI · Global X Funds | 0.15% | 174 NS | 2026年4月30日 | N-PORT |
| PTNQ · Pacer Funds Trust | 0.14% | 13104 NS | 2026年4月30日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.14% | 2485842 SH | 2026年8月8日 | 每日 |